Alogliptin
Description
Alogliptin is a potent and highly selective inhibitor of DPP-4, >10,000-fold more selective for DPP-4 than other related enzymes including DPP-8 and DPP-9. Alogliptin improves glycaemic control via a glucose-dependent mechanism, whereby insulin release is enhanced and glucagon levels are suppressed when glucose levels are high.
Medicine classification
Medicines
Australia Canada Singapore United States
Austria Lithuania Spain United Kingdom
Other medications with this active ingredient in combination: INCRESYNC KAZANO NESINA MET OSENI VIPDOMET
Product monographs
2D Molecule Structure
Unique Ingredient Identifier (UNII)
JHC049LO86 - ALOGLIPTIN
CAS Registry Number
850649-61-5 - alogliptin
SNOMED-CT
702799001 - Alogliptin (substance)